Growing healthcare investments, improved diagnostic infrastructure, and rising awareness about early disease detection are positioning Asia-Pacific as one of the fastest-growing markets for radiopharmaceuticals.
In recent years, demand for radiopharmaceuticals has surged, driven by rising incidences of chronic conditions such as cancer, cardiovascular disease, and neurological disorders. The...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek